CVE:ZOMD

Zoomd (ZOMD-X)

2.04
-0.02 (0.97%)
as of Aug 22, 2025, 7:59:54 pm Market Open.
4 watching
0

Related posts

Nervous markets await Nvidia

Most recent Opinions go here

Be up to date, don’t miss your chance.

HOLD
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

Sales rose 40% to $19.6M. EBITDA rose 80% to $5.6M. Net income was $6.1M vs $3.9M last year. Cash flow was $5.2M, with cash at $16.5M. North America and Europe were highlight areas. Costs rose slower than sales so margins improved. We would consider these results very good and with the gain in market cap and valuation we can see why the stock is doing very well this year.
Unlock Premium - Try 5i Free  

HOLD
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

Sales rose 40% to $19.6M. EBITDA rose 80% to $5.6M. Net income was $6.1M vs $3.9M last year. Cash flow was $5.2M, with cash at $16.5M. North America and Europe were highlight areas. Costs rose slower than sales so margins improved. We would consider these results very good and with the gain in market cap and valuation we can see why the stock is doing very well this year.
Unlock Premium - Try 5i Free    

COMMENT
Communication device between doctor and pharmacist. Great product. Federal government is encouraging electronic equipment like this and he is expecting it to come to some kind of agreement over the next 3 months but need money in the meantime.
BUY
Emerging development stage. Doesn’t have a ton of cash. May be able to get some cash from the government.
COMMENT
Communication device going from doctor to pharmacy. Have had good success. Good customer base. Still at the early stages. A micro cap and still needs to be well financed in order to expand its technology to be used in every hospital in North America. Good track record to now.
BUY
Has raised capital. Produces a hand held company to assist primary care physicians, to help electronic prescribing. It doesn’t cost the physician anything. The company is doing very well.
WEAK BUY
Communication device for doctors relaying prescriptions to the pharmacy. Not in his database. Big installed base in Quebec and rolling into Ontario. Very speculative.
Showing 1 to 7 of 7 entries
  • «
  • 1
  • »

Zoomd(ZOMD-X) Rating

Ranking : 3 out of 5

Star iconStar iconStar iconStar empty iconStar empty icon

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 2

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 2

Stockchase rating for Zoomd is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Zoomd(ZOMD-X) Frequently Asked Questions

What is Zoomd stock symbol?

Zoomd is a Canadian stock, trading under the symbol ZOMD-X on the TSX Venture Exchange (ZOMD-CV). It is usually referred to as TSXV:ZOMD or ZOMD-X

Is Zoomd a buy or a sell?

In the last year, 2 stock analysts published opinions about ZOMD-X. 0 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Zoomd.

Is Zoomd a good investment or a top pick?

Zoomd was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Zoomd.

Why is Zoomd stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Zoomd worth watching?

In the last year, there was no coverage of Zoomd published on Stockchase.

What is Zoomd stock price?

On 2025-08-22, Zoomd (ZOMD-X) stock closed at a price of $2.04.